Suppr超能文献

基于吡唑基乙基苯甲酰胺结构框架,从双重食欲素受体1/2拮抗剂衍生出高选择性和强效食欲素受体1拮抗剂的鉴定。

Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide.

作者信息

Futamura Aya, Nozawa Dai, Araki Yuko, Tamura Yunoshin, Tokura Seiken, Kawamoto Hiroshi, Tokumaru Yuichi, Kakihara Sora, Aoki Takeshi, Ohtake Norikazu

机构信息

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama 331-9530, Japan.

出版信息

Bioorg Med Chem. 2017 Oct 15;25(20):5203-5215. doi: 10.1016/j.bmc.2017.07.051. Epub 2017 Jul 29.

Abstract

The design, synthesis, and structure activity relationships of the novel class of pyrazolylethylbenzamide orexin receptor 1-selective antagonists are described. Further derivatization of the prototype dual orexin receptor 1/2 antagonist lead (1) by installing a (S)-methyl group into the ethyl linker moiety between the pyrazole ring and benzamide resulted in an increase of the antagonist potency against orexin receptor 1/2 receptors. Optimization of the benzamide and pyrazole parts of compounds 2 and 9b led to the identification of N-ethyl-5-fluoro-N-{(2S)-1-[5-(4-fluorophenyl)-2H-tetrazol-2-yl]propan-2-yl}-2-(pyrimidin-2-yl)benzamide (24), which exhibited excellent antagonistic activity against orexin receptor 1 with an IC of 2.01nM and a 265-fold selectivity for orexin receptor 1 over orexin receptor 2.

摘要

本文描述了新型吡唑基乙基苯甲酰胺类食欲素受体1选择性拮抗剂的设计、合成及其构效关系。通过在吡唑环和苯甲酰胺之间的乙基连接部分引入一个(S)-甲基,对原型双食欲素受体1/2拮抗剂先导物(1)进行进一步衍生化,导致其对食欲素受体1/2的拮抗活性增强。对化合物2和9b的苯甲酰胺和吡唑部分进行优化,得到了N-乙基-5-氟-N-{ (2S)-1-[5-(4-氟苯基)-2H-四唑-2-基]丙烷-2-基}-2-(嘧啶-2-基)苯甲酰胺(24),它对食欲素受体1表现出优异的拮抗活性,IC为2.01 nM,对食欲素受体1的选择性是食欲素受体2的265倍。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验